/DXCM
DexCom, Inc.
DXCM • NASDAQDXCM • NASDAQ • Healthcare
$72.90-0.25%-0.18
$72.90-0.25%(-0.18)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
80Bullish
Risk
59Moderate
Momentum
54Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
60.1%▼0.4pp
Revenue after COGS
Operating
19.6%▲4.7pp
After operating expenses
Net
17.9%▲3.7pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
31.0
Price vs earnings
EV/EBITDA
22.7
Enterprise value
FCF Yield
4.2%
Cash generation
Earnings Yield
3.2%
Inverse of P/E
Capital Efficiency
20
GoAI Quality ScoreStrong
ROEReturn on Equity
30.5%Strong
ROAReturn on Assets
13.2%Strong
ROICReturn on Invested Capital
16.6%Strong
Financial Health
Current RatioHealthy
1.88
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
0.41x
Debt repayment capacity (<3x)
Income QualityStrong
1.72
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B |
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating Income | $911.80M | $600.00M | $597.70M | $391.20M | $265.80M |
| Net Income | $836.30M | $576.20M | $541.50M | $341.20M | $216.90M |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% |
| EPS | $2.14 | $1.46 | $1.44 | $0.88 | $0.56 |
Average Price Target
$85.82▲ 17.7% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for DexCom, Inc., the average price target is $85.82, with a high forecast of $95.00 and a low forecast of $72.00. The average price target represents a 17.7% increase from the current price of $72.90.
Highest
$95.00
Average
$85.82
Lowest
$72.00
Rating Distribution
Strong Buy
1
2%
Buy
41
79%
Hold
8
15%
Sell
2
4%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
BTIG● Maintain
Buy
2026-02-25Truist Securities● Maintain
Buy
2026-02-17Mizuho● Maintain
Outperform
2026-02-13Wells Fargo● Maintain
Overweight
2026-02-13Barclays● Maintain
Underweight
2026-02-13BTIG● Maintain
Buy
2026-02-13Canaccord Genuity● Maintain
Buy
2026-02-13Barclays▼ Downgrade
Equal Weight→Underweight
2026-01-12Bernstein● Maintain
Outperform
2026-01-09Mizuho● Maintain
Outperform
2025-12-17Earnings History & Surprises
BEAT RATE
72%
Last 18 quarters
AVG SURPRISE
+10.5%
EPS vs Estimate
BEATS / MISSES
13/4
1 met exactly
LATEST EPS
$0.68
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+4.6%
$0.68 vs $0.65
Q4 '25
+5.9%
$0.61 vs $0.58
Q3 '25
+8.2%
$0.48 vs $0.44
Q2 '25
-2.2%
$0.32 vs $0.33
Q1 '25
-6.1%
$0.45 vs $0.48
Q4 '24
+2.3%
$0.45 vs $0.44
Q3 '24
+10.3%
$0.43 vs $0.39
Q2 '24
+18.5%
$0.32 vs $0.27
Q1 '24
+16.3%
$0.50 vs $0.43
Q4 '23
+47.1%
$0.50 vs $0.34
Q3 '23
+47.8%
$0.34 vs $0.23
Q2 '23
+13.3%
$0.17 vs $0.15
No investor questions available.
Latest News
No news available